|
1
|
Wang H, Xu T, Jiang Y, Xu H, Yan Y, Fu D
and Chen J: The challenges and the promise of molecular targeted
therapy in malignant gliomas. Neoplasia. 17:239–255. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Demuth T and Berens ME: Molecular
mechanisms of glioma cell migration and invasion. J Neurooncol.
70:217–228. 2004. View Article : Google Scholar
|
|
3
|
See SJ and Gilbert MR: Anaplastic
astrocytoma: Diagnosis, prognosis, and management. Semin Oncol.
31:618–634. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang CL, Wang JY, Liu ZY, Ma XM, Wang XW,
Jin H, Zhang XP, Fu D, Hou LJ and Lu YC: Ubiquitin-specific
protease 2a stabilizes MDM4 and facilitates the p53-mediated
intrinsic apoptotic pathway in glioblastoma. Carcinogenesis.
35:1500–1509. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang X, Zhu Y, Ma Y, Wang J, Zhang F, Xia
Q and Fu D: The role of cancer stem cells in cancer metastasis: New
perspective and progress. Cancer Epidemiol. 37:60–63. 2013.
View Article : Google Scholar
|
|
6
|
Srinivasan S, Patric IRP and Somasundaram
K: A ten-microRNA expression signature predicts survival in
glioblastoma. PLoS One. 6:e174382011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen X, Hao B, Han G, Liu Y, Dai D, Li Y,
Wu X, Zhou X, Yue Z, Wang L, et al: miR-372 regulates glioma cell
proliferation and invasion by directly targeting PHLPP2. J Cell
Biochem. 116:225–232. 2015. View Article : Google Scholar
|
|
8
|
Shang C, Hong Y, Guo Y, Liu YH and Xue YX:
MiR-210 up-regulation inhibits proliferation and induces apoptosis
in glioma cells by targeting SIN3A. Med Sci Monit. 20:2571–2577.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chen W, Zhang B, Guo W, Gao L, Shi L, Li
H, Lu S, Liu Y and Li X: miR-429 inhibits glioma invasion through
BMK1 suppression. J Neurooncol. 125:43–54. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan Y, Zhang L, Xu T, Zhou J, Qin R, Chen
C, Zou Y, Fu D, Hu G, Chen J, et al: SAMSN1 is highly expressed and
associated with a poor survival in glioblastoma multiforme. PLoS
One. 8:e819052013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Xu T, Jiang Y, Yan Y, Wang H, Lu C, Xu H,
Li W, Fu D, Lu Y and Chen J: VSIG4 is highly expressed and
correlated with poor prognosis of high-grade glioma patients. Am J
Transl Res. 7:1172–1180. 2015.PubMed/NCBI
|
|
12
|
Qin R, Zhou J, Chen C, Xu T, Yan Y, Ma Y,
Zheng Z, Shen Y, Lu Y, Fu D, et al: LIN28 is involved in glioma
carcinogenesis and predicts outcomes of glioblastoma multiforme
patients. PLoS One. 9:e864462014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang Q, Wang JY, Zhang XP, Lv ZW, Fu D, Lu
YC, Hu GH, Luo C and Chen JX: RLIP76 is overexpressed in human
glioblastomas and is required for proliferation, tumorigenesis and
suppression of apoptosis. Carcinogenesis. 34:916–926. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Vlachos IS, Paraskevopoulou MD, Karagkouni
D, Georgakilas G, Vergoulis T, Kanellos I, Anastasopoulos IL,
Maniou S, Karathanou K, Kalfakakou D, et al: DIANA-TarBase v7.0:
indexing more than half a million experimentally supported
miRNA:mRNA interactions. Nucleic Acids Res. 43(D1): D153–D159.
2015. View Article : Google Scholar :
|
|
15
|
Manterola L, Guruceaga E, Gállego
Pérez-Larraya J, González-Huarriz M, Jauregui P, Tejada S,
Diez-Valle R, Segura V, Samprón N, Barrena C, et al: A small
noncoding RNA signature found in exosomes of GBM patient serum as a
diagnostic tool. Neuro Oncol. 16:520–527. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Tumilson CA, Lea RW, Alder JE and Shaw L:
Circulating microRNA biomarkers for glioma and predicting response
to therapy. Mol Neurobiol. 50:545–558. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zemp FJ, McKenzie BA, Lun X, Reilly KM,
McFadden G, Yong VW and Forsyth PA: Cellular factors promoting
resistance to effective treatment of glioma with oncolytic myxoma
virus. Cancer Res. 74:7260–7273. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Grant R, Kolb L and Moliterno J: Molecular
and genetic pathways in gliomas: The future of personalized
therapeutics. CNS Oncol. 3:123–136. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shi L, Cheng Z, Zhang J, Li R, Zhao P, Fu
Z and You Y: hsa-miR-181a and hsa-mir-181b function as tumor
suppressors in human glioma cells. Brain Res. 1236:185–193. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wu SD, Ma YS, Fang Y, Liu LL, Fu D and
Shen XZ: Role of the microenvironment in hepatocellular carcinoma
development and progression. Cancer Treat Rev. 38:218–225. 2012.
View Article : Google Scholar
|
|
21
|
Wang Y, Ma Y, Fang Y, Wu S, Liu L, Fu D
and Shen X: Regulatory T cell: A protection for tumour cells. J
Cell Mol Med. 16:425–436. 2012. View Article : Google Scholar
|
|
22
|
Janelidze S, Lindqvist D, Francardo V,
Hall S, Zetterberg H, Blennow K, Adler CH, Beach TG, Serrano GE,
van Westen D, et al: Increased CSF biomarkers of angiogenesis in
Parkinson disease. Neurology. 85:1834–1842. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Holash J, Wiegand SJ and Yancopoulos GD:
New model of tumor angiogenesis: Dynamic balance between vessel
regression and growth mediated by angiopoietins and VEGF. Oncogene.
18:5356–5362. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Tsai YC, Lee CS, Chiu YW, Kuo HT, Lee SC,
Hwang SJ, Kuo MC and Chen HC: Angiopoietin-2 as a prognostic
biomarker of major adverse cardiovascular events and all-cause
mortality in chronic kidney disease. PLoS One. 10:e01351812015.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Stewart TA, Yapa KT and Monteith GR:
Altered calcium signaling in cancer cells. Biochim Biophys Acta.
1848(10 Pt B): 2502–2511. 2015. View Article : Google Scholar
|
|
26
|
Han DY, Fu D, Xi H, Li QY, Feng LJ, Zhang
W, Ji G, Xiao JC and Wei Q: Genomic expression profiling and
bioinformatics analysis of pancreatic cancer. Mol Med Rep.
12:4133–4140. 2015.PubMed/NCBI
|
|
27
|
Kashima H, Wu RC, Wang Y, Sinno AK,
Miyamoto T, Shiozawa T, Wang TL, Fader AN and Shih IeM: Laminin C1
expression by uterine carcinoma cells is associated with tumor
progression. Gynecol Oncol. 139:338–344. 2015. View Article : Google Scholar : PubMed/NCBI
|
